Ideal for companies within the pharmaceutical and life sciences industries, the solution hopes to solve counterfeit medicine trafficking and false counterfeit challenges.
Throughout the certification process, the company has implemented a series of sustainability measures including energy-saving initiatives, transitioning to reusable materials, and introducing recycling programs for laboratory supplies.
The solution aims to efficiently capture cell-free DNA directly from bodily fluids to improve early disease detection, treatment monitoring, and personalised medicine.
